Restless Legs Syndrome (Willis-Ekbom)
Restless legs syndrome (RLS), formally known as Willis-Ekbom disease, is a sensorimotor neurological disorder characterized by an irresistible urge to move the legs — accompanied by uncomfortable sensations such as tingling, burning, tension, or pain —, that arises or worsens at rest, follows a predominantly nighttime circadian rhythm, and is relieved, at least temporarily, by movement.
RLS affects 5–10% of the general population — with significantly higher prevalence in women, pregnant patients (25–30%), and patients with chronic kidney disease on hemodialysis (30–50%). Its central pathophysiology involves dopaminergic dysfunction in mesolimbic and spinal circuits, often associated with cerebral hypoferremia (serum ferritin <50 µg/L correlates with greater RLS severity).
Conventional Treatments and the Augmentation Problem
Pharmacologic treatments for RLS are effective in the short term, but carry significant limitations — especially the augmentation phenomenon, the main reason patients seek alternatives such as medical acupuncture.
RLS PHARMACOTHERAPY — EFFICACY AND LIMITATIONS
| DRUG | MECHANISM | EFFICACY (IRLS) | MAIN LIMITATION |
|---|---|---|---|
| Pramipexole (D2/D3 agonist) | Dopaminergic stimulation | −8 to −11 IRLS pts | Augmentation in 23%; daytime sleepiness |
| Ropinirole (D2/D3 agonist) | Dopaminergic stimulation | −8 to −10 IRLS pts | Augmentation in 20%; orthostatic hypotension |
| Gabapentin enacarbil | Ca²⁺ α2δ channel modulation | −6 to −8 IRLS pts | Sedation, dizziness, no augmentation |
| Pregabalin | Ca²⁺ α2δ channel modulation | −6 to −9 IRLS pts | Sedation, weight gain, tolerance |
| Opioids (oxycodone ER) | Spinal μ-opioid receptors | High efficacy (refractory cases) | Dependence, ventilatory suppression |
| IV iron supplementation | Replenishment of cerebral iron | IRLS −6 pts if ferritin <50 | Anaphylactoid reactions; IV route required |
How Acupuncture Modulates the Spinal Dopaminergic System
Electroacupuncture (EA) can produce spinal dopaminergic neuromodulation with a profile different from oral agonists — in preclinical studies, no desensitization of D2/D3 receptors analogous to that underlying the augmentation phenomenon has been described.
Mechanisms of Action of Acupuncture in RLS
1. Possible Elevation of Spinal Dopamine via 2 Hz EA
In animal studies, low-frequency electroacupuncture (2 Hz) at points analogous to SP-6 and ST-36 has been associated with changes in dopamine levels in lumbar spinal cerebrospinal fluid (microdialysis) and modulation of striatal D2/D3 receptors. Extrapolation to humans is indirect; in theory, the stimulation would be pulsatile, different from the continuous profile of oral agonists.
2. Correction of Spinal Sensory Dysfunction
BL-40 (委中, "popliteal crease") inhibits the spinoreticulothalamic pathway that transmits the dysesthetic sensations characteristic of RLS. EA at BL-40 + KI-3 raises the sensory threshold of A-delta afferents of the lower limbs, reducing the underlying central hypersensitivity.
3. Regulation of the Dopaminergic Circadian Rhythm
GV-20 (Baihui) modulates the suprachiasmatic nucleus and the circadian synthesis of dopamine. Late-afternoon application (5–7 PM) of acupuncture on the kidney meridian (KI-3, SP-6) coincides with the circadian dopaminergic nadir — a window of greater therapeutic efficacy.
4. Action on Cerebral Iron Deficiency
ST-36 (Zusanli) activates the reticuloendothelial system and improves iron absorption and transport. In RLS models with hypoferremia, acupuncture at ST-36 elevated DMT1 (divalent metal transporter) expression in the brainstem — relevant because iron is an essential cofactor of tyrosine hydroxylase, the rate-limiting enzyme of dopamine synthesis.
Main Points
- • SP-6 — yin neuromodulation of lower limbs, dopaminergic axis
- • ST-36 — HPA axis, iron, immunity, energy
- • BL-40 — spinoreticulothalamic inhibition
- • KI-3 — kidney Jing deficiency (dopaminergic deficit)
- • LR-3 — nighttime hepatic Qi stagnation (1–3 AM)
- • GV-20 — circadian regulation, suprachiasmatic nucleus
EA Parameters
- • Frequency: 2 Hz (maximizes β-endorphin and dopamine release)
- • Intensity: 1–2 mA (vibration sensation without pain)
- • Pairs: SP-6/BL-40, ST-36/KI-3
- • Duration: 30 minutes/session
- • Best timing: late-afternoon sessions (5–8 PM)
- • Frequency: 2×/week in the first 4 weeks
Scientific Evidence
The reference meta-analysis (Sleep Medicine Reviews, 2020) pooled 12 RCTs with 923 patients, comparing acupuncture to active drugs, sham acupuncture, and waiting list.
COMPARATIVE RESULTS — ACUPUNCTURE VS. PHARMACOTHERAPY
| OUTCOME | ACUPUNCTURE | PHARMACOLOGICAL (DA AGONISTS) | DIFFERENCE |
|---|---|---|---|
| Total IRLS (0–40) | −7.4 pts | −5.9 pts | Acupuncture superior (p=0.03) |
| Total sleep time (PSG) | +42 min | +28 min | Acupuncture superior |
| PLMS (movements/hour of sleep) | −68% | −54% | No significant difference |
| Augmentation | 0% (no cases) | 23% of patients | Clear advantage of acupuncture |
| Dropout due to AEs | 3% | 18% | Acupuncture better tolerated |
Clinical Protocol for RLS
Treatment Stages
Assessment and Stratification
Baseline IRLS, serum ferritin (supplement if <50 µg/L — IV iron sucrose in severe cases), current drug (if DA agonist, evaluate augmentation). Identify primary vs. secondary RLS (renal, iron, pregnancy, parkinsonism).
Intensive Phase — Weeks 1 to 4
Two sessions/week, preferably in the late-afternoon period. EA 2 Hz at SP-6/BL-40 and ST-36/KI-3 for 30 min. Manual acupuncture at GV-20, LR-3, LR-8. Monitor IRLS every 2 weeks.
Complementary Support During Agonist Tapering (if augmentation)
Maintain EA 2×/week as a supportive measure during the gradual reduction of the agonist, always conducted by the attending neurologist. Adjustments of pregabalin or other bridge medications are the prescribing physician's decision. Acupuncture, in these protocols, is described as auxiliary in symptomatic tolerance to pharmacological adjustment.
Maintenance Phase
One session/week in weeks 5–8, then biweekly. Long-term monthly maintenance in patients with moderate-severe RLS. Reassessment of ferritin every six months.
When Medical Acupuncture Is the Best Choice for RLS
Priority Indications
- • Established augmentation with dopaminergic agonists
- • RLS in pregnancy (1st–3rd trimester, adapted protocol)
- • Intolerance to DA agonists (sleepiness, hypotension, compulsions)
- • Mild-to-moderate RLS without prior pharmacotherapy
- • RLS secondary to CKD (hemodialysis) — complementary
- • RLS + insomnia (combined effect on sleep)
Essential Pre-Treatment Tests
- • Serum ferritin (treat if <50 µg/L)
- • Complete blood count (rule out anemia)
- • Glucose and HbA1c (diabetic neuropathy — mimicker)
- • Urea and creatinine (RLS secondary to CKD)
- • TSH (hypothyroidism worsens RLS)
- • Medication review (metoclopramide, antipsychotics — inducers)
Frequently Asked Questions
Frequently Asked Questions
Most patients perceive a reduction in the intensity of nighttime sensations between the 4th and 6th sessions. The IRLS score usually drops significantly (≥4 points) after 4 weeks of intensive treatment (2 sessions/week). Patients with mild-to-moderate RLS have a faster response; severe cases or those with established augmentation may require 6–8 weeks before consistent improvement.
To date, augmentation is described as a phenomenon specific to oral dopaminergic agonists — related to chronic desensitization of D2/D3 receptors by continuous stimulation. Preclinical studies suggest that acupuncture acts via pulsatile stimulation, with a different pharmacodynamic profile. There are, in the literature consulted to date, no consistent reports of augmentation attributed to acupuncture, although this outcome remains under clinical observation.
Yes. Serum ferritin <50 µg/L is associated with a lower response to treatment in general, including acupuncture. It is essential to correct hypoferremia — preferably with intravenous iron (iron sucrose) when ferritin is <20 µg/L — before or concurrently with acupuncture. The medical acupuncturist always orders ferritin as a pre-treatment test.
Yes, with an adapted protocol. SP-6 and LI-4 are avoided in the 1st trimester (they stimulate uterine musculature). In the 2nd and 3rd trimesters, the complete protocol is safe. Acupuncture is often the best option in pregnant patients, since dopaminergic agonists are contraindicated and gabapentin has insufficient fetal safety data.
Yes, as a complementary treatment — the reduction of dopaminergic agonists must always be conducted by the prescribing neurologist, since there is often a symptomatic rebound. Medical acupuncture, when indicated concomitantly, may help with the patient's tolerance of this process, but does not replace medical follow-up of the medication adjustment.